Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
Abstract The rapid structural evolution and emergence of novel synthetic cannabinoid receptor agonists (SCRAs) in the recreational market remains a key public health concern. Despite representing one of the largest classes of new psychoactive substances, pharmacological data on new SCRAs is limited,...
Saved in:
Main Authors: | Monica Patel (Author), Natasha L. Grimsey (Author), Samuel D. Banister (Author), David B. Finlay (Author), Michelle Glass (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
by: Mikkel Søes Ibsen, et al.
Published: (2019) -
Exploring determinants of agonist efficacy at the CB1 cannabinoid receptor: Analogues of the synthetic cannabinoid receptor agonist EG‐018
by: David B. Finlay, et al.
Published: (2022) -
Differential activation of G protein‐mediated signaling by synthetic cannabinoid receptor agonists
by: Shivani Sachdev, et al.
Published: (2020) -
CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
by: Richard C. Kevin, et al.
Published: (2019) -
Cannabinoid Receptor 2 Signalling Bias Elicited by 2,4,6-Trisubstituted 1,3,5-Triazines
by: Caitlin R. M. Oyagawa, et al.
Published: (2018)